NF-κB RelA-deficient lymphocytes: Normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responses

Journal of Experimental Medicine

Volumn 185, Issue 5, 1997, Pages 953-961

  Doi, Takahiro S ^a   Takahashi, Toshitada ^a   Taguchi, Osamu ^a   Azuma, Takachika ^b   Obata, Yuichi ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE ACTIVATION; CELL MATURATION; EMBRYO; FETUS LIVER; IMMUNE DEFICIENCY; IMMUNOMODULATION; LIVER TRANSPLANTATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ANIMALS; B-LYMPHOCYTES; CELL TRANSPLANTATION; FETAL TISSUE TRANSPLANTATION; GENES, LETHAL; HETEROZYGOTE; HOMOZYGOTE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERLEUKIN-2; LIVER TRANSPLANTATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MICE, SCID; NF-KAPPA B; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTES; TRANSCRIPTION FACTOR RELA;

EID: 0030999057     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.185.5.953     Document Type: Article

References (44)

1. Baldwin, A.S., Jr. 1996. The NF-κB and IκB proteins: New discoveries and insights. Annu. Rev. Immunol. 14:649-681.
2. Sen, R., and D. Baltimore. 1986. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell. 46:705-716.
3. Baeuerle, P.A., and T. Henkel. 1994. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12: 141-179.
4. Liou, H.-C., W.C. Sha, M.L. Scott, and D. Baltimore. 1994. Sequential induction of NF-κB/Rel family protein during B-cell terminal differentiation. Mol. Cell. Biol. 14:5349-5359.
5. Verweij, C.L., M. Geerts, and L.A. Aarden. 1991. Activation of interleukin-2 gene transcription via T-cell surface molecule CD28 is mediated through an NF-κB-like response element. J. Biol. Chem. 266:14179-14182.
6. Jamieson, C., F. Mauxion, and R. Sen. 1989. Identification of a functional NF-κB binding site in the murine T cell receptor β2 locus. J. Exp. Med. 170:1737-1743.
7. Ghosh, P., T.-H. Tan, N.R. Rice, A. Sica, and H.A. Young. 1993. The interleukin 2 CD28-responsive complex contains at least three members of the NF-κB family: c-Rel, p50, and p65. Proc. Natl Acad. Sci. USA. 90:1696-1700.
8. Libermann, T.A., and D. Baltimore. 1990. Activation of interleukin-6 gene expression through the NF-κB transcription factor. Mol. Cell. Biol. 10:2327-2334.
9. Collart, M.A., P. Baeuerle, and P. Vassalli. 1990. Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four κB-like motifs and of constitutive and inducible forms of NF-κB. Mol. Cell. Biol. 10:1498-1506.
10. Jamieson, C., P.G. McCaffrey, A. Rao, and R. Sen. 1991. Physiologic activation of T cells via the T cell receptor induces NF-κB. J. Immunol. 147:416-420.
11. Beg, A.A., W.C. Sha, R.T. Bronson, S. Ghosh, and D. Baltimore. 1995. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature (Lond.). 376:167-170.
12. Kontgen, F., R.J. Grumont, A. Strasser, D. Metcalf, R. Li, D. Tarlinton, and S. Gerondakis. 1995. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-expression. Genes Dev. 9: 1965-1977.
13. Weih, F., D. Carrasco, S.K. Durham, D.S. Barton, C.A. Rizzo, R.-P. Ryseck, S.A. Lira, and R. Bravo. 1995. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/ Rel family. Cell. 80:331-340.
14. Sha, W.C., H.-C. Liou, E.I. Toumanen, and D. Baltimore. 1995. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell. 80:321-330.
15. Beg, A.A., W.C. Sha, R.T. Bronson, and D. Baltimore. 1995. Constitutive NF-κB activation, enhanced granulopoiesis, and neonatal lethality in IκBα-deficient mice. Genes Dev. 9:2736-2746.
16. Nolan, G.P., S. Ghosh, H.-C. Liou, P. Tempst, and D. Baltimore. 1991. DNA binding and IκB inhibition of the cloned p65 subunit of NF-κB, a rel-related polypeptide. Cell. 64: 961-969.
17. Evans, M.J., and M.H. Kaufman. 1981. Establishment in culture of pluripotential cells from mouse embryos. Nature (Land.). 292:154-156.
18. Mansour, S.L., K.R. Thomas, and M.R. Capecchi. 1988. Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes. Nature (Lond.). 336:348-352.
19. Blin, N., and D.W. Stafford. 1976. A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acids Res. 3:2303-2308.
20. Chirgwin, J.M., A.E. Przybyla, R.J. MacDonald, and W.J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 18:5294-5299.
21. Bull, P., K.L. Morley, M.F. Hoekstra, T. Hunter, and I.M. Verma. 1990. The mouse c-rel protein has an N-terminal regulatory domain and a C-terminal transcriptional transactivation domain. Mol. Cell. Biol 10:5473-5485.
22. Ghosh, S., A.M. Gifford, L.R. Riviere, P. Tempst, G.P. Nolan, and D. Baltimore. 1990. Cloning of the p50 DNA binding subunit of NF-κB: homology to rel and dorsal. Cell. 62: 1019-1029.
23. Ryseck, R.-P., P. Bull, M. Takamiya, V. Bours, U. Siebenlist, P. Dobrzanski, and R. Bravo. 1992. RelB, a new Rel family transcription activator that can interact with p50-NF-κB. Mol. Cell. Biol. 12:674-684.
24. Bosma, G.C., R.P. Custer, and M.J. Bosnia. 1983. A severe combined immunodeficiency mutation in the mouse. Nature (Lond.). 301:527-530.
25. Kirchgessner, C.U., C.K. Patil, J.W. Evans, C.A. Cuomo, L.M. Fried, T. Carter, M.A. Oettinger, and J.M. Brown. 1995. DNA-dependent kinase (p350) as a candidate gene for the murine SCID defect. Science (Wash. DC). 267:1178-1183.
26. Kubo, R.T., W. Born, J.W. Kappler, P. Marrack, and M. Pigeon. 1989. Characterization of a monoclonal antibody which detects all murine αβ T cell receptors. J. Immunol. 142:2736-2742.
27. Leo, O., M. Foo, D.H. Sachs, L.E. Samelson, and J.A. Blue-stone. 1987. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc. Natl. Acad. Sci. USA. 84: 1374-1378.
28. Dialynas, D.P., Z.S. Quan, K.A. Wall, A. Pierres, J. Quintans, M.R. Loken, M. Pierres, and F.W. Fitch. 1983. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. J. Immunol. 131: 2445-2551.
29. Ledbetter, J., and L. Herzenberg. 1979. Xenogenic monoclonal antibodies to mouse lymphoid differentiation antigen. Immunol. Rev. 47:63-90.
30. Malek, T.R., R.J. Robb, and E.M. Shvach. 1983. Identification and initial characterization of a rat monoclonal antibody reactive with the murine interleukin 2 receptor-ligand complex. Proc. Natl. Acad. Sci. USA. 80:5694-5698.
31. Matsutake, T., T. Sasaki, T. Ogino, M. Kaku, and E. Nakayama. 1995. Prevention of mortality by in vivo depletion of αβ T cells in murine lethal listeriosis and involvement of γδ T cells in bacterial elimination. Immunol. 193:71-83.
32. Gavrieli, Y., Y. Sherman, and S.A. Ben-Sasson. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:493-501.
33. Sgonic, R., G. Boeck, H. Dietrich, J. Grhber, H. Recheis, and G. Wick. 1994. Simultaneous determination of cell surface antigens and apoptosis. Trends Genet. 10:41-42.
34. Carrasco, D., F. Weih, and R. Bravo. 1994. Developmental expression of the mouse c-rel proto-oncogene in hematopoietic organs. Development. 120:2991-3004.
35. Carrasco, D., R.-P. Ryseck, and R. Bravo. 1993. Expression of relB transcripts during lymphoid organ development: specific expression in dendritic antigen-presenting cells. Development. 118:1221-1231.
36. Johnson, G.R., and R.O. Jones. 1973. Differentiation of the mammalian hepatic primordium in vitro. I. Morphogenesis and the onset of hematopoiesis. J. Embryol. Exp. Morphol. 30: 83-96.
37. Clevers, H.C., and R. Grosschedl. 1996. Transcriptional control of lymphoid development: lessons from gene targeting. Immunol. Today. 17:336-343.
38. Ramsay, A.J., A.J. Husband, I.A. Ramshaw, S. Bao, K.I. Matthaei, G. Koehler, and M. Kopf. 1994. The role of interleukin-6 in mucosal IgA antibody responses in vivo. Science (Wash. DC). 264:561-563.
39. Lai, J., G. Horvath, J. Subleski, J. Bruder, P. Ghosh, and T. Tan. 1995. RelA is a potent transcriptional activator of the CD28 response element within the interleukin 2 promoter. Mol. Cell. Biol. 15:4260-4271.
40. Algarte, M., P. Lecine, R. Costello, A. Plet, D. Olive, and J. Imbert. 1995. In vivo regulation of interleukin-2 receptor α gene transcription by the coordinated binding of constitutive and inducible factors in human primary T cells. EMBO (Eur. Mol. Biol. Organ.) J. 20:5060-5072.
41. Gerondakis, S., A. Strasser, D. Metcalf, G. Grigoriadis, J.-P.Y. Scheerlinck, and R.J. Grumont. 1996. Rel-deficient T cells exhibit defects in production of interleukin 3 and granulo-cyte-macrophage colony stimulating factor. Proc. Natl. Acad. Sci. USA. 93:3405-3409.
42. Geppert, T.D., L.S. Davis, H. Gur, M.C. Wacholtz, and P.E. Lipsky. 1990. Accessory cell signals involved in T-cell activation. Immunol. Rev. 117:5-66.
43. Gold, M.R., and A.L. Defranco. 1994. Biochemistry of B lymphocyte activation. Adv. Immunol. 55:221-295.
44. Grumont, R.J., and S. Gerondakis. 1990. The murine c-rel proto-oncogene encodes two mRNAs the expression of which is modulated by lymphoid stimuli. Oncogene Res. 5: 245-254.